35 Ill. Adm. Code 611.743
Filtration
Section 611
Section 611.743Â Filtration
A PWS must provide treatment
consisting of both disinfection, as specified in Section 611.242, and
filtration treatment that complies with the requirements of subsection (a) or
(b) or Section 611.250(b) or (c).
a)Â Â Â Â Â Â Â Â Conventional Filtration Treatment or Direct Filtration
1)Â Â Â Â Â Â Â Â For a supplier using conventional filtration or direct
filtration, the turbidity level of representative samples of a system's
filtered water must be less than or equal to 0.3 NTU in at least 95 percent of
the measurements taken each month, measured as specified in Sections 611.531
and 611.533.
2)Â Â Â Â Â Â Â Â The turbidity level of representative samples of a supplier's
filtered water must at no time exceed 1 NTU, measured as specified in Sections
611.531 and 611.533.
3)Â Â Â Â Â Â Â Â A supplier that uses lime softening may acidify representative
samples prior to analysis using a protocol approved by the Agency.
b)Â Â Â Â Â Â Â Â Filtration Technologies Other Than Conventional Filtration
Treatment, Direct Filtration, Slow Sand Filtration, or Diatomaceous Earth
Filtration. A PWS supplier may use a filtration technology not listed in
subsection (a) or in Section 611.250(b) or (c) if it demonstrates to the
Agency, using pilot plant studies or other means, that the alternative
filtration technology, in combination with disinfection treatment that meets
the requirements of Section 611.242(b), consistently achieves 99.9 percent
removal or inactivation of Giardia lamblia cysts and 99.99 percent removal or
inactivation of viruses, and 99 percent removal of Cryptosporidium oocysts, and
the Agency approves the use of the filtration technology. For each approval,
the Agency must set turbidity performance requirements that the supplier must
meet at least 95 percent of the time and that the supplier must not exceed at
any time at a level that consistently achieves 99.9 percent removal or
inactivation of Giardia lamblia cysts, 99.99 percent removal or inactivation of
viruses, and 99 percent removal of Cryptosporidium oocysts.
BOARD NOTE:Â Derived from 40 CFR
141.173.